Pancreatic Cancer Research

ResearcherUniversity of New MexicoActive in the last 2 years

Ian Rabinowitz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3377-4865; OpenAlex author ID A5082131768. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Synthetic lethality targets in pancreatic ductal adenocarcinoma: prevalence and limitations of liquid biopsy detection in a minority-serving cancer center. Last author DOI 10.1080/14796694.2026.2699426↗
  2. The inflammatory response of human pancreatic cancer samples compared to normal controls. Last author DOI 10.1371/journal.pone.0284232↗
  3. Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy. Last author DOI 10.1159/000510096↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mahmoud Abdelsamia · 1 shared paper, 2026 · strength 0.43
  2. Kathryn J. Brayer · 1 shared paper, 2023 · strength 0.22
  3. Shenthol Sasankan · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.